Bulletin
Investor Alert

New York Markets Open in:

Rubius Therapeutics Inc.

NAS: RUBY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204835982/composite

$

6.96

Change

0.00 0.00%

Volume

Volume 2,345

Jan 26, 2022, 4:01 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204835982/composite

Previous close

$ 7.26

$ 6.96

Change

-0.30 -4.13%

Day low

Day high

$6.88

$7.53

Open
Open: 7.40

52 week low

52 week high

$6.75

$38.71

Open

Market cap

$652.43M

Average volume

492,036

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.12

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ruby

MarketWatch News on RUBY

  1. Will Biotech Stocks' Slide Become a Rout? June Holds the Key.

    1:46 p.m. May 14, 2021

    - Barron's Online

  2. 'Natural Killer Cells' and Other Promising Cancer Treatments

    11:30 a.m. April 15, 2021

    - Barron's Online

  3. Rubius Therapeutics downgraded to neutral from overweight at J.P. Morgan

    7:54 a.m. Jan. 31, 2020

    - Tomi Kilgore

  4. Rubius Therapeutics stock price target cut to $22 vs. $27 at JPMorgan

    7:42 a.m. Aug. 29, 2019

    - Ciara Linnane

  5. Rubius Therapeutics started at overweight with $37 stock price target at Morgan Stanley

    8:46 a.m. Aug. 13, 2018

    - Tomi Kilgore

  6. Rubius Therapeutics started at overweight with $28 stock price target at J.P. Morgan

    6:40 a.m. Aug. 13, 2018

    - Tomi Kilgore

  7. Rubius Therapeutics started at outperform with $30 stock price target at Leerink

    6:04 a.m. Aug. 13, 2018

    - Tomi Kilgore

  8. Rubius Therapeutics shares surge 35% in trading debut

    10:02 a.m. July 18, 2018

    - Ciara Linnane

  9. Rubius Therapeutics shares surge 35% in trading debut

    9:59 a.m. July 18, 2018

    - Ciara Linnane

  10. Rubius Therapeutics prices IPO at $23 a share

    9:11 p.m. July 17, 2018

    - Sue Chang

/news/nonmarketwatch/company/us/ruby

Other News on RUBY

  1. Warning: RUBY is at high risk of performing badly

    4:33 a.m. Dec. 10, 2021

    - Seeking Alpha

  2. Warning: RUBY is at high risk of performing badly

    4:48 a.m. Nov. 26, 2021

    - Seeking Alpha

  3. Warning: RUBY is at high risk of performing badly

    4:54 a.m. Nov. 10, 2021

    - Seeking Alpha

  4. 10-Q: RUBIUS THERAPEUTICS, INC.

    4:36 p.m. Nov. 8, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  5. Warning: RUBY is at high risk of performing badly

    3:59 a.m. Oct. 28, 2021

    - Seeking Alpha

  6. Warning: RUBY is at high risk of performing badly

    8:55 a.m. Oct. 12, 2021

    - Seeking Alpha

  7. RUBY is at high risk of performing badly

    3:30 a.m. Oct. 12, 2021

    - Seeking Alpha

  8. 10-Q/A: RUBIUS THERAPEUTICS, INC.

    3:19 p.m. Aug. 20, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  9. 10-Q: RUBIUS THERAPEUTICS, INC.

    7:23 a.m. Aug. 9, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  10. Rubius Therapeutics appoints new operations chief

    7:16 a.m. July 29, 2021

    - Seeking Alpha

  11. Our Read On Rubius Therapeutics

    8:48 a.m. July 11, 2021

    - Seeking Alpha

  12. Rubius Therapeutics doses first patient in RTX-240 cancer study

    3:07 p.m. June 23, 2021

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/ruby

Press Releases on RUBY

  1. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/207732364/composite MSFT-2.66%
  • /zigman2/quotes/203165245/composite T+0.53%
  • /zigman2/quotes/213120645/composite DKNG-3.54%
  • /zigman2/quotes/209901640/composite SPY-1.22%
  • /zigman2/quotes/209958550/composite AUPH+3.30%
X
Powered by StockTwits
Link to MarketWatch's Slice.